Lineage Cell Therapeutics (LCTX) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NYSE: LCTX) | Delayed: 1.00 -0.03 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $ | |||
| Open | $1.04 | 52 Week Low | $ | |||
| Day High | $1.05 | P/E | N/A | |||
| Day Low | $0.98 | EPS | $ | |||
| Volume | 1,166,442 | |||||
